NGGT Progresses First US Gene Therapy Trials For Rare Conditions

Supported By China Data

 
• By Dexter Jie Yan
  
US China flags
NGGT leveraging China's large rare disorder patient pools to speed up US trials • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia